Nj State Employees Deferred Compensation Plan Cytokinetics Inc Transaction History
Nj State Employees Deferred Compensation Plan
- $824 Million
- Q3 2024
A detailed history of Nj State Employees Deferred Compensation Plan transactions in Cytokinetics Inc stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 15,500 shares of CYTK stock, worth $766,630. This represents 0.1% of its overall portfolio holdings.
Number of Shares
15,500
Previous 15,500
-0.0%
Holding current value
$766,630
Previous $839,000
2.5%
% of portfolio
0.1%
Previous 0.11%
Shares
2 transactions
Others Institutions Holding CYTK
# of Institutions
405Shares Held
125MCall Options Held
4.61MPut Options Held
2.46M-
Black Rock Inc. New York, NY14.7MShares$726 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$582 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.69MShares$479 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.77MShares$385 Million0.07% of portfolio
-
State Street Corp Boston, MA6.46MShares$319 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.66B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...